Biktarvy, formally known as bictegravir, represents a potent single-tablet regimen for controlling HIV infection. This drug integrates three crucial antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It works by blocking the the viral ability to copy within the body, considerably decreasing the viral burden. For many ind